Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section
Recruiting · NCT07343843 · Interventional (participants receive a specific treatment) · Lead sponsor: Benha University
View the official record on ClinicalTrials.gov →Interventions studied
DexmedetomidineVirtual reality
What this trial is about
This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age over 18 years old.
- American Society of Anesthesiologists (ASA) physical status II.
- Scheduled for elective cesarean section (CS) delivery under Central Neuraxial Blockade.
- Provide informed consent and agree to participate in the study.
Exclusion criteria
- Patient's refusal
- Patient known have contraindications for Regional Anesthesia as infection at the site of injection, severe coagulopathy or allergy to local anesthetics.
- Patient with psychiatric disorders.
- Sensory impairment (blindness, deafness).
- Any technical problem preventing proper fitting of the glasses to the patient face.
- Patients with cognitive impairment, epilepsy or with claustrophobia
- Patients with suspected eye infection
- Signs of active labor.
- Pregnancy related-diseases or antepartum hemorrhage.
- Presence of Fetal distress.
Where it is running
1 location listed.
- Benha University - Banhā, Benha, Egypt